Cataract surgery lowers IOP by 18% in patients with untreated ocular hypertension, a surgeon reported, giving results derived from the Ocular Hypertension Treatment Study.
Changes In IOP After Cataract Removal Reported For Observation Group Of The OHTS
Cataract surgery lowers IOP by 18% in patients with untreated ocular hypertension, a surgeon reported, giving results derived from the Ocular Hypertension Treatment Study.
NICE Consults On A New Drug To Treat Diabetic Macular Oedema
In draft guidance issued yesterday, NICE has not recommended ranibizumab (Lucentis, Novartis) for treating diabetic macular oedema (DMO). This draft guidance has been issued for consultation. NICE has not yet issued final guidance to the NHS…
ISTA Pharmaceuticals Files Citizen Petition (CP) With U.S. Food And Drug Administration
ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA), announced it filed a Citizen Petition (CP) with the U.S. Food and Drug Administration (FDA) on March 1, 2011. The CP requests the FDA refrain from granting tentative or final approval of any abbreviated new dr…
ISTA Pharmaceuticals Files Citizen Petition (CP) With U.S. Food And Drug Administration
ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA), announced it filed a Citizen Petition (CP) with the U.S. Food and Drug Administration (FDA) on March 1, 2011. The CP requests the FDA refrain from granting tentative or final approval of any abbreviated new dr…
Stem Cells in Ophthalmology Update 5: Gene Defects Common in Induced Stem Cells
As the senior editor, John Gever, of MedPage Today reported, following the publication of three studies about induced pluripotent stem cells in the March 3rd, issue of Nature, “The road to regenerative medicine based on induced pluripotent stem cells…